A Berkeley Lab spin-out, Newomics is creating blood-based assays for diabetes diagnosis and management, and for the monitoring of environmental toxins, among other health care applications. The core technology, a multi-nozzle emitter array (MEA) for mass spectrometry, was developed by Newomics founder and president Daojing Wang, a guest scientist in Biological Systems and Engineering (BSE), while he was in the Lab’s Life Sciences Division (now part of the Biosciences Area). Collaborators on the emitter technology included Pan Mao, formerly in Life Sciences, and Peidong Yang in the Materials Sciences Division. Read more in the Berkeley Lab News Center.
ABPDU Partners with Small Businesses in DOE Pilot
Through the second round of the U.S. Department of Energy (DOE) Small Business Vouchers Pilot, eight small businesses have been awarded vouchers, totaling $1.1 million, to work with Berkeley Lab to bring their next-generation clean energy to the marketplace faster. The vouchers pay for expertise and use of facilities that help small businesses advance their technologies toward commercialization. Several Biosciences partnerships were established: Mango Materials and Zymochem bioenergy projects were awarded vouchers to work with the Advanced Biofuels Process Demonstration Unit (ABPDU). Also, a Heliobiosys project will be performed using the capabilities of both the ABPDU and Sandia National Laboratories. The Lab was chosen by the DOE as one of five national laboratories to lead the pilot and was named a lead lab in the Advanced Manufacturing, Fuel Cells, Geothermal and Vehicle technology areas.
Was this page useful?
Send
